Royal Philips has strengthened its earnings forecast after receiving €186 million ($211 million) in refunds from the United States on previously imposed tariffs.
The Dutch healthcare technology company confirmed the cash recovery on Tuesday, marking a significant reversal of trade costs that had weighed on its import operations.
The refund represents almost the entirety of the duties Philips had paid, providing a direct boost to profitability.
This development follows a second-quarter report in which the company’s profit margins already exceeded market expectations, largely driven by early indications of these tariff reimbursements.
The influx of cash improves the company’s liquidity position and supports its broader financial guidance.
Philips is among the first major multinationals to successfully navigate the new US tariff refund program, alongside peers such as Pandora.